Literature DB >> 27620367

Biomimetic Cardiac Tissue Model Enables the Adaption of Human Induced Pluripotent Stem Cell Cardiomyocytes to Physiological Hemodynamic Loads.

Aaron J Rogers1,2, Vladimir G Fast2, Palaniappan Sethu1,2.   

Abstract

Induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) provide a human source of cardiomyocytes for use in cardiovascular research and regenerative medicine. However, attempts to use these cells in vivo have resulted in drastic cell death caused by mechanical, metabolic, and/or exogenous factors. To explore this issue, we designed a Biomimetic Cardiac Tissue Model (BCTM) where various parameters associated with heart function including heart rate, peak-systolic pressure, end-diastolic pressure and volume, end-systolic pressure and volume, and ratio of systole to diastole can all be precisely manipulated to apply hemodynamic loading to culture cells. Using the BCTM, two causes of low survivability in current cardiac stem cell therapies, mechanical and metabolic, were explored. iPSC-CMs were subject to physiologically relevant mechanical loading (50 mmHg systolic, 10% biaxial stretch) in either a low- or high-serum environment and mechanical loads were applied either immediately or gradually. Results confirm that iPSC-CMs subject to mechanical loading in low-serum conditions experienced widespread cell death. The rate of application of stress also played an important role in adaptability to mechanical loading. Under high-serum conditions, iPSC-CMs subject to gradual imposition of stress were comparable to iPSC-CMs maintained in static culture when evaluated in terms of cell viability, sarcomeric structure, action potentials and conduction velocities. In contrast, iPSC-CMs that were immediately exposed to mechanical loading had significantly lower cell viability, destruction of sarcomeres, smaller action potentials, and lower conduction velocities. We report that iPSC-CMs survival under physiologically relevant hemodynamic stress requires gradual imposition of mechanical loads in a nutrient-rich environment.

Entities:  

Mesh:

Year:  2016        PMID: 27620367      PMCID: PMC6050012          DOI: 10.1021/acs.analchem.6b03105

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  32 in total

1.  On-chip immunoprecipitation for protein purification.

Authors:  Mairi E Sandison; Sarah A Cumming; Walter Kolch; Andrew R Pitt
Journal:  Lab Chip       Date:  2010-08-17       Impact factor: 6.799

2.  Pulsatile perfusion bioreactor for cardiac tissue engineering.

Authors:  Melissa A Brown; Rohin K Iyer; Milica Radisic
Journal:  Biotechnol Prog       Date:  2008 Jul-Aug

Review 3.  Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.

Authors:  Olalla Iglesias-García; Beatriz Pelacho; Felipe Prósper
Journal:  J Mol Cell Cardiol       Date:  2013-04-30       Impact factor: 5.000

4.  Cardiac Gab1 deletion leads to dilated cardiomyopathy associated with mitochondrial damage and cardiomyocyte apoptosis.

Authors:  J Zhao; M Yin; H Deng; F Q Jin; S Xu; Y Lu; M A Mastrangelo; H Luo; Z G Jin
Journal:  Cell Death Differ       Date:  2015-10-30       Impact factor: 15.828

5.  Surface chemical modification of poly(dimethylsiloxane) for the enhanced adhesion and proliferation of mesenchymal stem cells.

Authors:  Shreyas Kuddannaya; Yon Jin Chuah; Min Hui Adeline Lee; Nishanth V Menon; Yuejun Kang; Yilei Zhang
Journal:  ACS Appl Mater Interfaces       Date:  2013-09-23       Impact factor: 9.229

Review 6.  Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview.

Authors:  Christine L Mummery; Jianhua Zhang; Elizabeth S Ng; David A Elliott; Andrew G Elefanty; Timothy J Kamp
Journal:  Circ Res       Date:  2012-07-20       Impact factor: 17.367

7.  Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.

Authors:  Jacqueline S Wendel; Lei Ye; Ran Tao; Jianyi Zhang; Jianhua Zhang; Timothy J Kamp; Robert T Tranquillo
Journal:  Stem Cells Transl Med       Date:  2015-09-14       Impact factor: 6.940

8.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.

Authors:  Michael A Laflamme; Kent Y Chen; Anna V Naumova; Veronica Muskheli; James A Fugate; Sarah K Dupras; Hans Reinecke; Chunhui Xu; Mohammad Hassanipour; Shailaja Police; Chris O'Sullivan; Lila Collins; Yinhong Chen; Elina Minami; Edward A Gill; Shuichi Ueno; Chun Yuan; Joseph Gold; Charles E Murry
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

9.  Isolation, culture, and functional characterization of adult mouse cardiomyoctyes.

Authors:  Evan Lee Graham; Cristina Balla; Hannabeth Franchino; Yonathan Melman; Federica del Monte; Saumya Das
Journal:  J Vis Exp       Date:  2013-09-24       Impact factor: 1.355

10.  Gene expression profiles in engineered cardiac tissues respond to mechanical loading and inhibition of tyrosine kinases.

Authors:  Fei Ye; Fangping Yuan; Xiaohong Li; Nigel Cooper; Joseph P Tinney; Bradley B Keller
Journal:  Physiol Rep       Date:  2013-10-02
View more
  13 in total

1.  Noninvasive Quantification of Cell Density in Three-Dimensional Gels by MRI.

Authors:  Brian J Archer; Till Uberruck; Julia J Mack; Khalid Youssef; Nanette N Jarenwattananon; Deniz Rall; Denis Wypysek; Martin Wiese; Bernhard Blumich; Matthias Wessling; M Luisa Iruela-Arispe; Louis-S Bouchard
Journal:  IEEE Trans Biomed Eng       Date:  2018-07-18       Impact factor: 4.538

2.  Cardiac Tissue Chips (CTCs) for Modeling Cardiovascular Disease.

Authors:  Aaron J Rogers; Jessica M Miller; Ramaswamy Kannappan; Palaniappan Sethu
Journal:  IEEE Trans Biomed Eng       Date:  2019-03-18       Impact factor: 4.538

3.  Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering.

Authors:  Bin Jiang; Li Yan; James G Shamul; Maxwell Hakun; Xiaoming He
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

4.  Microfluidic systems for modeling human development.

Authors:  Makenzie G Bonner; Hemanth Gudapati; Xingrui Mou; Samira Musah
Journal:  Development       Date:  2022-02-14       Impact factor: 6.868

Review 5.  Opportunities and challenges in cardiac tissue engineering from an analysis of two decades of advances.

Authors:  Richard Z Zhuang; Roberta Lock; Bohao Liu; Gordana Vunjak-Novakovic
Journal:  Nat Biomed Eng       Date:  2022-04-27       Impact factor: 29.234

6.  Therapeutic Ultrasound Effects on Human Induced Pluripotent Stem Cell Cardiomyocytes Measured Optically and with Spectral Ultrasound.

Authors:  Andrew W Chen; George Saab; Aleksandar Jeremic; Vesna Zderic
Journal:  Ultrasound Med Biol       Date:  2022-03-15       Impact factor: 3.694

7.  Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues.

Authors:  Ilya Y Shadrin; Brian W Allen; Ying Qian; Christopher P Jackman; Aaron L Carlson; Mark E Juhas; Nenad Bursac
Journal:  Nat Commun       Date:  2017-11-28       Impact factor: 14.919

Review 8.  Naturally Engineered Maturation of Cardiomyocytes.

Authors:  Gaetano J Scuderi; Jonathan Butcher
Journal:  Front Cell Dev Biol       Date:  2017-05-05

Review 9.  Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering.

Authors:  Miguel F Tenreiro; Ana F Louro; Paula M Alves; Margarida Serra
Journal:  NPJ Regen Med       Date:  2021-06-01

10.  Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice.

Authors:  Kah Yong Goh; Li He; Jiajia Song; Miki Jinno; Aaron J Rogers; Palaniappan Sethu; Ganesh V Halade; Namakkal Soorappan Rajasekaran; Xiaoguang Liu; Sumanth D Prabhu; Victor Darley-Usmar; Adam R Wende; Lufang Zhou
Journal:  Redox Biol       Date:  2019-01-08       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.